Barclays Maintains an 'Equalweight' on Calix (CALX); Healthy Spending Trends Continue

February 22, 2011 2:03 PM EST Send to a Friend
Barclays maintains an 'Equalweight' on Calix (NYSE: CALX), PT $19.

Barclays analyst says, "We emerged encouraged by Calix' growth prospects ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login